Vascular effects of prostacyclin

Does activation of PPARδ play a role?

Zvonimir S Katusic, Anantha V. Santhanam, Tongrong He

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Prostacyclin (PGI2) is a potent vasodilator that exerts multiple vasoprotective effects in the cardiovascular system. The effects of PGI 2 are mediated by activation of the cell membrane G-protein-coupled PGI2 receptor (IP receptor). More recently, however, it has been suggested that PGI2 might also serve as an endogenous ligand and activator of nuclear peroxisome proliferator-activated receptorδ (PPARδ). Consistent with this concept, studies designed to define pharmacological properties of stable PGI2 analogs revealed that beneficial effects of these compounds appear to be mediated, in part, by activation of PPARδ. This review discusses emerging evidence regarding the contribution of PPARδ activation to vasoprotective and regenerative functions of PGI2 and stable analogs of PGI2.

Original languageEnglish (US)
Pages (from-to)559-564
Number of pages6
JournalTrends in Pharmacological Sciences
Volume33
Issue number10
DOIs
StatePublished - Oct 2012

Fingerprint

Peroxisome Proliferator-Activated Receptors
Epoprostenol
Blood Vessels
Chemical activation
Epoprostenol Receptors
Cardiovascular system
Cell membranes
G-Protein-Coupled Receptors
Cardiovascular System
Vasodilator Agents
GTP-Binding Proteins
Membrane Proteins
Pharmacology
Ligands

ASJC Scopus subject areas

  • Pharmacology
  • Toxicology

Cite this

Vascular effects of prostacyclin : Does activation of PPARδ play a role? / Katusic, Zvonimir S; Santhanam, Anantha V.; He, Tongrong.

In: Trends in Pharmacological Sciences, Vol. 33, No. 10, 10.2012, p. 559-564.

Research output: Contribution to journalArticle

Katusic, Zvonimir S ; Santhanam, Anantha V. ; He, Tongrong. / Vascular effects of prostacyclin : Does activation of PPARδ play a role?. In: Trends in Pharmacological Sciences. 2012 ; Vol. 33, No. 10. pp. 559-564.
@article{52dcc45037544672a542af5bc6eeeb68,
title = "Vascular effects of prostacyclin: Does activation of PPARδ play a role?",
abstract = "Prostacyclin (PGI2) is a potent vasodilator that exerts multiple vasoprotective effects in the cardiovascular system. The effects of PGI 2 are mediated by activation of the cell membrane G-protein-coupled PGI2 receptor (IP receptor). More recently, however, it has been suggested that PGI2 might also serve as an endogenous ligand and activator of nuclear peroxisome proliferator-activated receptorδ (PPARδ). Consistent with this concept, studies designed to define pharmacological properties of stable PGI2 analogs revealed that beneficial effects of these compounds appear to be mediated, in part, by activation of PPARδ. This review discusses emerging evidence regarding the contribution of PPARδ activation to vasoprotective and regenerative functions of PGI2 and stable analogs of PGI2.",
author = "Katusic, {Zvonimir S} and Santhanam, {Anantha V.} and Tongrong He",
year = "2012",
month = "10",
doi = "10.1016/j.tips.2012.05.005",
language = "English (US)",
volume = "33",
pages = "559--564",
journal = "Trends in Pharmacological Sciences",
issn = "0165-6147",
publisher = "Elsevier Limited",
number = "10",

}

TY - JOUR

T1 - Vascular effects of prostacyclin

T2 - Does activation of PPARδ play a role?

AU - Katusic, Zvonimir S

AU - Santhanam, Anantha V.

AU - He, Tongrong

PY - 2012/10

Y1 - 2012/10

N2 - Prostacyclin (PGI2) is a potent vasodilator that exerts multiple vasoprotective effects in the cardiovascular system. The effects of PGI 2 are mediated by activation of the cell membrane G-protein-coupled PGI2 receptor (IP receptor). More recently, however, it has been suggested that PGI2 might also serve as an endogenous ligand and activator of nuclear peroxisome proliferator-activated receptorδ (PPARδ). Consistent with this concept, studies designed to define pharmacological properties of stable PGI2 analogs revealed that beneficial effects of these compounds appear to be mediated, in part, by activation of PPARδ. This review discusses emerging evidence regarding the contribution of PPARδ activation to vasoprotective and regenerative functions of PGI2 and stable analogs of PGI2.

AB - Prostacyclin (PGI2) is a potent vasodilator that exerts multiple vasoprotective effects in the cardiovascular system. The effects of PGI 2 are mediated by activation of the cell membrane G-protein-coupled PGI2 receptor (IP receptor). More recently, however, it has been suggested that PGI2 might also serve as an endogenous ligand and activator of nuclear peroxisome proliferator-activated receptorδ (PPARδ). Consistent with this concept, studies designed to define pharmacological properties of stable PGI2 analogs revealed that beneficial effects of these compounds appear to be mediated, in part, by activation of PPARδ. This review discusses emerging evidence regarding the contribution of PPARδ activation to vasoprotective and regenerative functions of PGI2 and stable analogs of PGI2.

UR - http://www.scopus.com/inward/record.url?scp=84866742055&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84866742055&partnerID=8YFLogxK

U2 - 10.1016/j.tips.2012.05.005

DO - 10.1016/j.tips.2012.05.005

M3 - Article

VL - 33

SP - 559

EP - 564

JO - Trends in Pharmacological Sciences

JF - Trends in Pharmacological Sciences

SN - 0165-6147

IS - 10

ER -